Maravai LifeSciences Holdings Inc Ordinary Shares - Class A (MRVI)

Industry Biotechnology


This stock can be held in an Investment ISA and an Investment Account
Sell

$3.50

Buy

$4.00

arrow-down$-0.11 (-2.96%)

Prices updated at 12 Dec 2025, 21:10 EST
| Prices minimum 15 mins delay
|
Prices in USD

Sector
Healthcare
Industry
Biotechnology
Chairman
Mr. Robert Andrew Eckert
CEO
Mr. Bernd Brust
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
550
Head office
10770 Wateridge Circle
San Diego
United States
92121
mobile
+1 858 546-0004
letter
david.weber@maravai.com

Key personnel

Salary
Mr. Bernd Brust
Director and Chief Executive Officer
-
Mr. Rajesh J. Asarpota
Chief Financial Officer
-
Mr. Gregory T. Lucier
Independent Director
0.06m
Dr. John A. DeFord, PhD
Independent Director
0.09m
Ms. Christine Dolan
Executive Vice President and General Manager, Cygnus Technologies
-
Mr. Sean L. Cunningham
Director
0.07m
Mr. Constantine S. Mihas
Director
0.07m
Mr. Kurt Oreshack
General Counsel and Secretary
-
Ms. Susannah Gray, M.B.A.
Independent Director
0.10m
Mr. Luke Marker
Director
0.06m
Mr. Robert Andrew Eckert
Chairman of the Board
-

Top 5 shareholders

No. of shares
GTCR Investment XI LLC130,834,085
GTCR LLC20,150,005
12 West Capital Management LP12,521,335
Vanguard Group Inc9,380,547
BlackRock Inc9,103,866

Director dealings

Action
09 Dec 2024-
09 Dec 2024-
15 Nov 2024-
12 Nov 2024-
11 Nov 2024-
31 Oct 2024-
31 Oct 2024-
31 Oct 2024-
31 Oct 2024-
15 Oct 2024-
15 Jul 2024-
23 May 2024-
23 May 2024-
23 May 2024-
23 May 2024-
23 May 2024-
23 May 2024-
23 May 2024-
23 May 2024-
23 May 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.